1.A study on the genetic polymorphism of methylenetetrahydrofolate reductase in egnancy - induced hypertensive patient.
Young Ju KIM ; Jeffrey C MURRAY
Korean Journal of Obstetrics and Gynecology 2000;43(9):1569-1573
No abstract available.
Humans
;
Methylenetetrahydrofolate Reductase (NADPH2)*
;
Polymorphism, Genetic*
2.Homocysteine, folate, and methylenetetrahydrofolate reductase polymorphism in Korean normal subjects.
Korean Journal of Medicine 2000;58(2):248-249
No abstract available.
Folic Acid*
;
Homocysteine*
;
Methylenetetrahydrofolate Reductase (NADPH2)*
3.Association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and methotrexate toxicity in korean patients with rheumatoid arthritis.
Seong Kyu KIM ; Jae Bum JUN ; Ahmed El SOHEMY ; Yong Wook PARK ; Hye Soon LEE ; Wan Sik UHM ; Tae Hwan KIM ; Dae Hyun YOO ; Sang Cheol BAE
Korean Journal of Medicine 2004;67(2):121-130
BACKGROUND: This study was designed to identify the relationship between the C677T mutants of MTHFR and methotrexate toxicities in Korean patients with RA and to determine whether MTHFR polymorphism will be useful predictor for adverse effects of low dose methotrexate treatment. METHODS: We enrolled 385 (355 females, 30 males) patients with RA, who had been received low dose methotrexate. Genotypes of MTHFR polymorphism were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. The correlations between MTHFR genotypes, age, RF positivity, RA progression stage, KHAQ and adverse effects were analyzed by Spearman's rank correlation test. The frequency analysis of C677T genotype and adverse effects was done by Chi-square test. RESULTS: The results of MTHFR genotypic analysis showed 133 patients (34.6%) with 677CC, 193 patients (50.1%) with 677CT and 59 patients (15.3%) with 677TT. One hundred fifty-four of the 385 patients (40.0%) had methotrexate-related side effects. The significant correlation between toxicities of methotrexate and MTHFR polymorphism was identified by Spearman's rank correlation test (p<0.05). The odd ratio, which of adverse effects could be occurred by low dose methotrexate in rheumatoid arthritis patients with MTHFR polymorphism, showed higher value than other studies (p<0.001, OR: 4.0, 95% CI 2.45-6.51). CONCLUSION: There was a positive association between methotrexate-related toxicities and MTHFR polymorphism. This study suggested that C677T mutant of MTHFR might be a powerful genetic indicator in predicting the adverse effects of low dose methotrexate therapy in patient with rheumatoid arthritis.
Arthritis, Rheumatoid*
;
Female
;
Genotype
;
Humans
;
Methotrexate*
;
Methylenetetrahydrofolate Reductase (NADPH2)*
4.The Analysis of Methylenetetrahydrofolate Reductase Mutation in Recurrent Spontaneous Abortion.
Yoon Sung NAM ; Kwang Yul CHA ; Nam Keun KIM ; Sun Hee KIM ; Jin Woo LIM ; Geum Duk KANG ; Myung Seo KANG ; Se Hyun KIM ; Doyeun OH
Korean Journal of Fertility and Sterility 2001;28(3):247-
OBJECTIVE: To analyze the methylenetetrahydrofolate reductase (MTHFR) mutation in patients with recurrent spontaneous abortion. MATERIAL AND METHOD: The blood samples of patients with recurrent spontaneous abortion were tested by PCR-RFLP method. RESULTS: Of 51 cases of study group, 14 (27.5%) were normal, 25 (49.0%) were heterozygosity, and 12 (23.5%) were homozygosity. Of 58 cases of control group, 20 (34.5%) were normal, 30 (51.7%) were heterozygosity, and 8 (13.8%) were homozygosity. But the difference between two groups was not significant (p=0.190). CONCLUSION: Hyperhomocysteinemia due to MTHFR mutation is a cause of recurrent spontaneous abortion. Therefore, the study for MTHFR mutation should be included in the workup of recurrent spontaneous abortion.
Abortion, Spontaneous*
;
Female
;
Humans
;
Hyperhomocysteinemia
;
Methylenetetrahydrofolate Reductase (NADPH2)*
;
Pregnancy
5.Do methylenetetrahydrofolate dehydrogenase, cyclohydrolase, and formyltetrahydrofolate synthetase 1 polymorphisms modify changes in intelligence of school-age children in areas of endemic fluorosis?
Zichen FENG ; Ning AN ; Fangfang YU ; Jun MA ; Na LI ; Yuhui DU ; Meng GUO ; Kaihong XU ; Xiangbo HOU ; Zhiyuan LI ; Guoyu ZHOU ; Yue BA
Chinese Medical Journal 2022;135(15):1846-1854
BACKGROUND:
Excessive exposure to fluoride can reduce intelligence. Methylenetetrahydrofolate dehydrogenase, cyclohydrolase, and formyltetrahydrofolate synthetase 1 ( MTHFD1 ) polymorphisms have important roles in neurodevelopment. However, the association of MTHFD1 polymorphisms with children's intelligence changes in endemic fluorosis areas has been rarely explored.
METHODS:
A cross-sectional study was conducted in four randomly selected primary schools in Tongxu County, Henan Province, from April to May in 2017. A total of 694 children aged 8 to 12 years were included in the study with the recruitment by the cluster sampling method. Urinary fluoride (UF) and urinary creatinine were separately determined using the fluoride ion-selective electrode and creatinine assay kit. Children were classified as the high fluoride group and control group according to the median of urinary creatinine-adjusted urinary fluoride (UF Cr ) level. Four loci of MTHFD1 were genotyped, and the Combined Raven's Test was used to evaluate children's intelligence quotient (IQ). Generalized linear model and multinomial logistic regression model were performed to analyze the associations between children's UF Cr level, MTHFD1 polymorphisms, and intelligence. The general linear model was used to explore the effects of gene-environment and gene-gene interaction on intelligence.
RESULTS:
In the high fluoride group, children's IQ scores decreased by 2.502 when the UF Cr level increased by 1.0 mg/L (β = -2.502, 95% confidence interval [CI]:-4.411, -0.593), and the possibility for having "excellent" intelligence decreased by 46.3% (odds ratio = 0.537, 95% CI: 0.290, 0.994). Children with the GG genotype showed increased IQ scores than those with the AA genotype of rs11627387 locus in the high fluoride group ( P < 0.05). Interactions between fluoride exposure and MTHFD1 polymorphisms on intelligence were observed (Pinteraction < 0.05).
CONCLUSION
Our findings suggest that excessive fluoride exposure may have adverse effects on children's intelligence, and changes in children's intelligence may be associated with the interaction between fluoride and MTHFD1 polymorphisms.
Child
;
Creatinine
;
Cross-Sectional Studies
;
Fluorides/urine*
;
Formate-Tetrahydrofolate Ligase
;
Humans
;
Intelligence/genetics*
;
Methylenetetrahydrofolate Dehydrogenase (NADP)
;
Methylenetetrahydrofolate Reductase (NADPH2)
6.The Analysis of Interrelationship between Homocysteine and Methylenetetrahydrofolate Reductase Mutation in Patients with Recurrent Spontaneous Abortion.
Yoon Sung NAM ; Kwang Yul CHA ; Nam Keun KIM ; Myung Seo KANG ; Se Hyun KIM ; Doyeon OH
Korean Journal of Fertility and Sterility 2002;29(3):187-194
OBJECTIVE: To analyze the interrelationship between homocysteine and methylenetetrahydrofolate reductase (MTHFR) mutation in patients with recurrent spontaneous abortion. MATERIAL AND METHOD: Homocysteine and MTHFR mutation were tested by fluorescent polarizing immunoassay and PCR-RFLP method, respectively. RESULTS: In patients with homocysteine level less than 5 mmol/L, there was no case of normal group but there were four cases of heterozygosity and one case of homozygosity. In patients with homocysteine level 5~10 mmol/L, the number of normal, heterozygosity and homozygosity group were eleven, eighteen and eight, respectively. In patients with homocysteine level 10~15 mmol/L, the number of normal, heterozygosity and homozygosity group were four, one and one, respectively. In patients with homocysteine level more than 15 mmol/L, there was no case of normal and heterozygosity group but there were two cases of homozygosity. CONCLUSIONS: Hyperhomocysteinemia due to MTHFR mutation is a cause of recurrent spontaneous abortion. And there was a significant relationship between homocysteine and MTHFR mutation.
Abortion, Spontaneous*
;
Female
;
Homocysteine*
;
Humans
;
Hyperhomocysteinemia
;
Immunoassay
;
Methylenetetrahydrofolate Reductase (NADPH2)*
;
Pregnancy
7.The Associtation between Methylenetetrahydrofolate Reductase Gene Polymorphisms and a Risk of Spontaneously Aborted Embryos.
Nick Beom JEON ; Seung Il JI ; Seung Joo SHIN ; Sun Hee CHA ; Dong Hee CHOI ; Dong Jin YIM ; Sang Hee PARK ; Suman LEE ; Sang Hwa LEE ; Jung Jae KO ; Nam Keun KIM
Korean Journal of Fertility and Sterility 2006;33(1):61-68
OBJECTIVE: This study was performed to understand the influence of the methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) genotypes on the spontaneously aborted embryos. METHODS: DNA was extracted from tissue samples of 95 spontaneously aborted embryos and 100 samples of normal children randomly and 449 samples of normal adults were selected as the controls. MTHFR genotypes were determined by a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. RESULTS: The aborted embryo group had higher frequency of MTHFR 677CC type (p=0.014) and lower 677CT type (p=0.063) than the controlled child group. The frequency of MTHFR 677CT type was drastically lower than that of controlled adult group (p=0.032). In the MTHFR C677T/A1298C combination, 677CC/1298AC genotype of the aborted embryo was significantly higher (p=0.034) than that of controlled child group, but it was not statistically significant in controlled adult group (p=0.063). CONCLUSION: MTHFR 677CC and MTHFR 677CC/1298AC genotypes may represent genetic markers for the risk of spontaneously aborted embryos at least in Koreans.
Aborted Fetus*
;
Adult
;
Child
;
DNA
;
Genetic Markers
;
Genotype
;
Homocysteine
;
Humans
;
Methylenetetrahydrofolate Reductase (NADPH2)*
8.Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Risk of Down Syndrome.
Kyu Young CHAE ; Jin Hee HAN ; Ji Yeong SEO ; Min Jung CHO ; Sehyun KIM ; Nam Keun KIM
Korean Journal of Pediatrics 2004;47(10):1053-1057
PURPOSE: The C677T polymorphism of the methylenetetrahydrofolate reductase(MTHFR) has been suggested as a risk factor of maternal meiotic nondisjunction for Down syndrome. Recently, a second genetic polymorphism in MTHFR at position 1298 was reported. However, a positive association between the A1298C MTHFR polymorphism and Down syndrome has not been reported. Therefore, this study was undertaken to determine which polymorphism of MTHFR gene was associated with the increased risk of a child suffering from Down syndrome(DS). METHODS: We enrolled 33 patients with Down syndrome and 100 healthy individuals and analyzed the MTHFR C677T and A1298C polymorphism by a PCR-restriction fragment length assay. RESULTS: Frequencies of MTHFR C677T genotypes(CC, CT, and TT) were 9(27%), 22(67%), and 2 (6%) in the DS patients and 24(24%), 55(55%) and 21(21%) in the control, respectively. The frequency of mutant 677TT was significantly low in the DS patients(OR : 0.14; 95% CI : 0.02-0.95; P= 0.04). For the MTHFR A1298C polymorphism, frequencies of genotypes(AA, AC, and CC) were 16(48 %), 15(45%) and 1(3%) in DS patients and 77(77%), 21(21%) and 2(2%) in the control, respectively. The frequency of mutant 1298AC was significantly increased in DS patients with an odds ratio of 3.3(95% CI : 1.39-7.82; P=0.007). CONCLUSION: Our results suggest that MTHFR mutant 677TT may have a protective effect against Down syndrome, but MTHFR mutant 1298AC may be an independent risk factor in Down syndrome.
Child
;
Down Syndrome*
;
Humans
;
Methylenetetrahydrofolate Reductase (NADPH2)*
;
Odds Ratio
;
Polymorphism, Genetic
;
Risk Factors
9.Hyper-homocysteinemia Inducing Hyperuricemia: What are the Mechanisms?.
Journal of Rheumatic Diseases 2017;24(3):127-130
Hyperuricemia is related to metabolic syndrome, and is defined as an over-production or under-excretion of uric acid (UA), with increased UA serum concentration. Among other causes, Hyper-homocysteinemia (H-Hcy) can be responsible for hyperuricemia. The mechanisms underlying the association between these two conditions are unclear, but increased UA serum levels can be a consequence of renovascular atherosclerosis, with reduced UA excretion. An alternative hypothesis is the over-production of UA from adenosine (originating from S-adenosyl-homocysteine). Genetic polymorphism (C677T) of methylenetetrahydrofolate reductase (MTHFR) may contribute. A possible mechanism is purines biosyinthesis originating from this gene variant. However, the results obtained from several studies and meta-analyses of the relationship between H-Hcy and hyperuricemia are ambivalent, and broader research is needed.
Adenosine
;
Atherosclerosis
;
Homocysteine
;
Hyperuricemia*
;
Methylenetetrahydrofolate Reductase (NADPH2)
;
Polymorphism, Genetic
;
Purines
;
Uric Acid
10.Relationship between Metabolic Syndrome and MTHFR Polymorphism in Colorectal Cancer.
Bong Su KANG ; Dae Ho AHN ; Nam Keun KIM ; Jong Woo KIM
Journal of the Korean Society of Coloproctology 2011;27(2):78-82
PURPOSE: There have been studies on the relations between metabolic syndrome and colorectal cancer or on the relations between methylenetetrahydrofolate reductase (MTHFR) polymorphism and colorectal cancer, but reports on the relationship between metabolic syndrome, MTHFR polymorphism and colorectal cancer all together are rare. The aim of this study is to find the interrelation between metabolic syndrome and MTHFR polymorphism in colorectal cancer. METHODS: This study investigated 255 colorectal cancer patients (cancer group) who underwent surgery in our hospital from March 2003 to December 2008 and compared those patients to 488 healthy patients (control group). The diagnostic criterion for metabolic syndrome was based on the National Cholesterol Education Program-Adult Treatment Panel III (NCEP ATP III), and the MTHFR 677 polymorphism was analyzed. RESULTS: When colorectal cancer patients and patients in the control group were classified as MTHFR 677 subtypes, there was no difference between the two groups: CC 87 (34.1%), CT 134 (52.6%), and TT 34 (13.3%) for the cancer group and CC 145 (32.4%), CT 238 (53.1%), and TT 65 (14.5%) for the control group. Distributions of MTHFR 677C/T genotype and allele frequencies in the individuals with and without metabolic syndrome in the cancer group showed no differences. Moreover, we could find no differences in distributions of MTHFR 677C/T genotypes in the clinical and the biomedical variables of individuals with and without metabolic syndrome in the cancer group. CONCLUSION: Our results show no relation between metabolic syndrome and MTHFR polymorphism in colorectal cancer. However, a further prospective study, based on a precise diagnostic criterion for metabolic syndrome, is needed.
Adenosine Triphosphate
;
Cholesterol
;
Colorectal Neoplasms
;
Gene Frequency
;
Genotype
;
Humans
;
Methylenetetrahydrofolate Reductase (NADPH2)